Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Danaher Corp DHR

Danaher Corporation is a global life sciences and diagnostics innovator. The Company operates through three business segments: Biotechnology, Life Sciences and Diagnostics. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a broad range of equipment, consumables and services that are primarily used by customers to advance and accelerate the... see more

Recent & Breaking News (NYSE:DHR)

INVESTOR ACTION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Danaher Corporation and Encourages Investors with Losses to Contact the Firm

Accesswire May 22, 2023

SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Danaher Corporation and Encourages Investors with Losses to Contact the Firm

Accesswire May 17, 2023

Beckman Coulter Unveils Next Generation Immunoassay Analyzer Enabling Elite Laboratory Performance with No Daily Maintenance

PR Newswire May 15, 2023

INVESTIGATION ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Danaher Corporation and Encourages Investors with Losses to Contact the Firm

Accesswire May 12, 2023

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Danaher Corporation - DHR

PR Newswire May 10, 2023

SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Danaher Corporation and Encourages Investors with Losses to Contact the Firm

Accesswire May 10, 2023

Danaher Announces Quarterly Dividend

PR Newswire May 9, 2023

Danaher to Present at Bank of America Securities Health Care Conference

PR Newswire May 3, 2023

SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Danaher Corporation and Encourages Investors with Losses to Contact the Firm

Accesswire May 3, 2023

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Danaher Corporation - DHR

PR Newswire May 2, 2023

ALDEVRON ANNOUNCES EXPANSION OF mRNA PRODUCTION CAPABILITY

PR Newswire May 1, 2023

SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Danaher Corporation and Encourages Investors with Losses to Contact the Firm

Accesswire April 28, 2023

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Danaher Corporation - DHR

PR Newswire April 27, 2023

INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Danaher Corporation and Encourages Investors with Losses to Contact the Firm

Newsfile April 27, 2023

INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Danaher Corporation and Encourages Investors with Losses to Contact the Firm

Business Wire April 26, 2023

SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Danaher Corporation and Encourages Investors with Losses to Contact the Firm

Accesswire April 26, 2023

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Danaher Corporation and Encourages Investors with Losses to Contact the Firm

Business Wire April 25, 2023

Danaher Reports First Quarter 2023 Results

PR Newswire April 25, 2023

Danaher Announces Conversion Date for Series B Mandatory Convertible Preferred Stock

PR Newswire April 10, 2023

Danaher Schedules First Quarter 2023 Earnings Conference Call

PR Newswire March 27, 2023